BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 28099082)

  • 1. Therapeutics Targeting Drivers of Thoracic Aortic Aneurysms and Acute Aortic Dissections: Insights from Predisposing Genes and Mouse Models.
    Milewicz DM; Prakash SK; Ramirez F
    Annu Rev Med; 2017 Jan; 68():51-67. PubMed ID: 28099082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-21 Knockout Exacerbates Angiotensin II-Induced Thoracic Aortic Aneurysm and Dissection in Mice With Abnormal Transforming Growth Factor-β-SMAD3 Signaling.
    Huang X; Yue Z; Wu J; Chen J; Wang S; Wu J; Ren L; Zhang A; Deng P; Wang K; Wu C; Ding X; Ye P; Xia J
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1086-1101. PubMed ID: 29519942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Clinical Trials of Losartan With and Without β-Blockers to Block Aneurysm Growth in Patients With Marfan Syndrome: A Review.
    Hofmann Bowman MA; Eagle KA; Milewicz DM
    JAMA Cardiol; 2019 Jul; 4(7):702-707. PubMed ID: 31066871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Smooth Muscle Cell Force Generation as a Driver of Thoracic Aortic Aneurysms and Dissections.
    Milewicz DM; Trybus KM; Guo DC; Sweeney HL; Regalado E; Kamm K; Stull JT
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):26-34. PubMed ID: 27879251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad2-dependent protease nexin-1 overexpression differentiates chronic aneurysms from acute dissections of human ascending aorta.
    Gomez D; Kessler K; Borges LF; Richard B; Touat Z; Ollivier V; Mansilla S; Bouton MC; Alkoder S; Nataf P; Jandrot-Perrus M; Jondeau G; Vranckx R; Michel JB
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2222-32. PubMed ID: 23814118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
    Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologically Improved Contractility Protects Against Aortic Dissection in Mice With Disrupted Transforming Growth Factor-β Signaling Despite Compromised Extracellular Matrix Properties.
    Ferruzzi J; Murtada SI; Li G; Jiao Y; Uman S; Ting MY; Tellides G; Humphrey JD
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):919-27. PubMed ID: 26988590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections.
    Inamoto S; Kwartler CS; Lafont AL; Liang YY; Fadulu VT; Duraisamy S; Willing M; Estrera A; Safi H; Hannibal MC; Carey J; Wiktorowicz J; Tan FK; Feng XH; Pannu H; Milewicz DM
    Cardiovasc Res; 2010 Dec; 88(3):520-9. PubMed ID: 20628007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms.
    Angelov SN; Hu JH; Wei H; Airhart N; Shi M; Dichek DA
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2102-2113. PubMed ID: 28729364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Naringenin inhibits thoracic aortic aneurysm formation in mice with Marfan syndrome].
    Li ZQ; Yu B; Cai ZY; Wang YB; Zhang X; Zhou B; Fang XH; Yu F; Fu Y; Sun JP; Li W; Kong W
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):896-906. PubMed ID: 36241232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome.
    Boileau C; Guo DC; Hanna N; Regalado ES; Detaint D; Gong L; Varret M; Prakash SK; Li AH; d'Indy H; Braverman AC; Grandchamp B; Kwartler CS; Gouya L; Santos-Cortez RL; Abifadel M; Leal SM; Muti C; Shendure J; Gross MS; Rieder MJ; Vahanian A; Nickerson DA; Michel JB; ; Jondeau G; Milewicz DM
    Nat Genet; 2012 Jul; 44(8):916-21. PubMed ID: 22772371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIPK2 Alleviates Thoracic Aortic Disease in Mice With Progressively Severe Marfan Syndrome.
    Caescu CI; Hansen J; Crockett B; Xiao W; Arnaud P; Spronck B; Weinberg A; Hashimoto T; Murtada SI; Borkar R; Gallo JM; Jondeau G; Boileau C; Humphrey JD; He JC; Iyengar R; Ramirez F
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2483-2493. PubMed ID: 34320838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic Stress Activates an Adaptive Program in Thoracic Aortic Smooth Muscle Cells That Maintains Aortic Strength and Protects Against Aneurysm and Dissection in Mice.
    Zhang C; Li Y; Chakraborty A; Li Y; Rebello KR; Ren P; Luo W; Zhang L; Lu HS; Cassis LA; Coselli JS; Daugherty A; LeMaire SA; Shen YH
    Arterioscler Thromb Vasc Biol; 2023 Feb; 43(2):234-252. PubMed ID: 36579645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome.
    Yang HH; Kim JM; Chum E; van Breemen C; Chung AW
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):305-312.e2. PubMed ID: 20189193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the Elastin-Contractile Units in the Thoracic Aorta and How Genes That Cause Thoracic Aortic Aneurysms and Dissections Disrupt This Structure.
    Karimi A; Milewicz DM
    Can J Cardiol; 2016 Jan; 32(1):26-34. PubMed ID: 26724508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.
    Cook JR; Clayton NP; Carta L; Galatioto J; Chiu E; Smaldone S; Nelson CA; Cheng SH; Wentworth BM; Ramirez F
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):911-7. PubMed ID: 25614286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional variant of
    Wang Y; Yin P; Chen YH; Yu YS; Ye WX; Huang HY; Ji ZC; Shen ZY
    Aging (Albany NY); 2018 Dec; 10(12):3683-3701. PubMed ID: 30530919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXE3 mutations predispose to thoracic aortic aneurysms and dissections.
    Kuang SQ; Medina-Martinez O; Guo DC; Gong L; Regalado ES; Reynolds CL; Boileau C; Jondeau G; Prakash SK; Kwartler CS; Zhu LY; Peters AM; Duan XY; Bamshad MJ; Shendure J; Nickerson DA; Santos-Cortez RL; Dong X; Leal SM; Majesky MW; Swindell EC; Jamrich M; Milewicz DM
    J Clin Invest; 2016 Mar; 126(3):948-61. PubMed ID: 26854927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapies for Thoracic Aortic Aneurysms and Acute Aortic Dissections.
    Milewicz DM; Ramirez F
    Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):126-136. PubMed ID: 30651002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis.
    Jones JA; Spinale FG; Ikonomidis JS
    J Vasc Res; 2009; 46(2):119-37. PubMed ID: 18765947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.